StockData
Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd (RDY) income statement

RDYNYSEPharmaceutical PreparationsFiscal year ends March 31
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Score 7/30
$14.98+0.19 (+1.28%)

Close on Nov 18, 2026Market cap $12.50BP/E 27.5Yield 0.57%

Dr Reddys Laboratories Ltd income statement

Ratios

Latest available, balances at Mar 31, 2026

Profitability, FY2026

Gross margin
52.8%
Operating margin
15.0%
Net margin
12.8%
Return on equity, FY2026
12.1%

Financial strength

Current ratio
1.80
Debt to equity
0.21
Debt to assets
13.3%
Cash to current liabilities
9.2%

Valuation

P/E ratio
27.5
Price to sales
3.51
Price to book
3.12
Dividend yield
0.57%

See a number that looks wrong?